Revenue
No reported data
Adaptin Bio, Inc. (APTN)
Price$6.27Cached quote
Net income
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Research & development | $1.8M | $1.8M | — |
| Operating expenses | $5.4M | $2.6M | — |
| Operating income | −$5.4M | −$2.6M | −$85,593 |
| Net income | −$5.2M | −$3.1M | −$85,593 |
| Basic EPSper basic share | -$0.66 | -$0.96 | -$0.02 |
| Diluted EPSper diluted share | -$0.66 | -$0.96 | -$0.02 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Lucius Partners LLC | 3.25M |
Roberts Michael J | 2.16M |
Pedder Simon | 928.57K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 4 ↗Updated Sep 29, 2026 · Quarterly data